Similar articles for PMID: 29928713

Year	Number of Results
2001	1
2006	2
2007	5
2008	5
2009	4
2010	4
2011	4
2012	10
2013	6
2014	3
2015	10
2016	9
2017	3
2018	7
2019	4
2024	0

1

Persistent microscopic active inflammatory lesions in the central nervous system of a patient with neuromyelitis optica treated with oral prednisolone for more than 40 years.

Fujii C, Itoh K, Saito K, Satoh Y, Makino M, Nakagawa M, Yamaguchi K, Fushiki S, Mizuno T. Fujii C, et al. eNeurologicalSci. 2018 May 23;11:17-19. doi: 10.1016/j.ensci.2018.05.005. eCollection 2018 Jun. eNeurologicalSci. 2018. PMID: 29928713 Free PMC article.

2

Harmel J, Ringelstein M, Ingwersen J, Mathys C, Goebels N, Hartung HP, Jarius S, Aktas O. Harmel J, et al. BMC Neurol. 2014 Dec 17;14:247. doi: 10.1186/s12883-014-0247-3. BMC Neurol. 2014. PMID: 25516429 Free PMC article.

3

Diagnosis and treatment of neuromyelitis optica.

Wingerchuk DM. Wingerchuk DM. Neurologist. 2007 Jan;13(1):2-11. doi: 10.1097/01.nrl.0000250927.21903.f8. Neurologist. 2007. PMID: 17215722 Review.

4

[Clinical characteristics and follow-up of pediatric patients with neuromyelitis optica and neuromyelitis optica spectrum disorders].

Yun W, Weihua Z, Xiaotun R, Jiuwei L, Xinying Y, Junlan L, Changhong D, Chunhong C, Haitao R, Liying C, Fang F. Yun W, et al. Zhonghua Er Ke Za Zhi. 2015 Apr;53(4):268-73. Zhonghua Er Ke Za Zhi. 2015. PMID: 26182501 Chinese.

5

Treatment of neuromyelitis optica: an evidence based review.

Sato D, Callegaro D, Lana-Peixoto MA, Fujihara K; Brazilian Committee for Treatment and Research in Multiple Sclerosis. Sato D, et al. Arq Neuropsiquiatr. 2012 Jan;70(1):59-66. doi: 10.1590/s0004-282x2012000100012. Arq Neuropsiquiatr. 2012. PMID: 22218475 Free article. Review.

6

Autoimmune thyroiditis associated with neuromyelitis optica (NMO).

Sudulagunta SR, Sodalagunta MB, Khorram H, Sepehrar M, Gonivada J, Noroozpour Z, Prasad N. Sudulagunta SR, et al. Ger Med Sci. 2015 Nov 18;13:Doc22. doi: 10.3205/000226. eCollection 2015. Ger Med Sci. 2015. PMID: 26633965 Free PMC article.

7

[Treatment of neuromyelitis optica].

Nomura K. Nomura K. Nihon Rinsho. 2013 May;71(5):829-38. Nihon Rinsho. 2013. PMID: 23777090 Review. Japanese.

8

Treatment of neuromyelitis optica and neuromyelitis optica spectrum disorders with rituximab using a maintenance treatment regimen and close CD19 B cell monitoring. A six-year follow-up.

Evangelopoulos ME, Andreadou E, Koutsis G, Koutoulidis V, Anagnostouli M, Katsika P, Evangelopoulos DS, Evdokimidis I, Kilidireas C. Evangelopoulos ME, et al. J Neurol Sci. 2017 Jan 15;372:92-96. doi: 10.1016/j.jns.2016.11.016. Epub 2016 Nov 10. J Neurol Sci. 2017. PMID: 28017256

9

Importance of Regular and Maintenance Therapy Adherence in Neuromyelitis Optica (NMO): Lessons from a Repeating Relapse Case.

Miao J, Aboagye DE, Chulpayev B, Liu L, Ishkanian G, Kolanuvada B, Alaie D, Petrillo RL. Miao J, et al. Am J Case Rep. 2018 Jan 11;19:41-46. doi: 10.12659/ajcr.906150. Am J Case Rep. 2018. PMID: 29321467 Free PMC article.

10

[Treatment and clinical management of patients with neuromyelitis optica and anti-aquaporin 4 antibody].

Ochi H. Ochi H. Brain Nerve. 2010 Sep;62(9):945-52. Brain Nerve. 2010. PMID: 20844305 Review. Japanese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

71 results

Results by year